Crescita Therapeutics Inc.
CRRTF
$0.54
$0.00-0.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -193.29% | -5.22% | 188.82% | -461.28% | 84.77% |
| Total Depreciation and Amortization | 5.74% | 9.29% | 3.70% | -5.64% | 13.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.12% | -559.97% | -32.32% | -225.73% | -52.77% |
| Change in Net Operating Assets | -46.41% | 167.41% | -847.69% | -87.19% | 6.14% |
| Cash from Operations | -64.96% | 38,809.09% | 99.38% | -136.36% | 216.18% |
| Capital Expenditure | 93.86% | -385.03% | -167.17% | 81.76% | 58.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 110.12% | -385.03% | -167.17% | 81.76% | 54.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -39.83% | -1.72% | 0.00% | -2.65% | -2.73% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -105.08% | -37.21% | 44.16% | 34.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.12% | -37.15% | -14.17% | 35.36% | -3.00% |
| Foreign Exchange rate Adjustments | -243.75% | 286.05% | -304.76% | -94.34% | 396.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.44% | 135.17% | 50.03% | -185.85% | 241.75% |